TELADOC HEALTH, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.01 USD | -2.40% |
|
+0.23% | -39.63% |
| Apr. 26 | UBS Adjusts Teladoc Price Target to $16 From $20, Maintains Neutral Rating | MT |
| Apr. 26 | Oppenheimer Cuts Teladoc's Price Target to $21 From $26, Maintains Outperform Rating | MT |
ETFs positioned on Teladoc Health, Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 4.31% | 1 M€ | 0.00% | - | |
| 4.28% | 1 M€ | 0.00% | - | |
| 4.08% | 0 M€ | 0.00% | - | |
| 1.08% | 16 M€ | -8.49% | ||
| 1.06% | 0 M€ | 0.00% | - | |
| 1.06% | 4 M€ | +10.27% | - | |
| 1.00% | 9 M€ | +22.75% | - | |
| 0.90% | 1 M€ | -.--% | - | |
| 0.64% | 2 M€ | -.--% | ||
| 0.34% | 18 M€ | +3.79% | - | |
| 0.22% | 7 M€ | -.--% | - | |
| 0.21% | 2 M€ | +6.77% | ||
| 0.07% | 9 M€ | -.--% | - | |
| 0.06% | 773 M€ | -.--% | - | |
| 0.05% | 1 M€ | +52.31% | - | |
| 0.05% | 2,510 M€ | +12.00% | ||
| 0.04% | 277 M€ | -.--% | - | |
| 0.04% | 194 M€ | +7.48% | - | |
| 0.04% | 441 M€ | +10.26% | ||
| 0.03% | 2,658 M€ | +10.56% | - |
Teladoc Health, Inc. provides virtual healthcare services. The Company operates through two segments: Teladoc Health Integrated Care (Integrated Care) and BetterHelp. The Integrated Care segment includes a suite of global virtual medical services including general medical, expert medical services, specialty medical, chronic condition management, mental health, and enabling technologies and enterprise telehealth solutions for hospitals and health systems. Services in this segment are distributed primarily on a business-to-business (B2B) basis. The BetterHelp segment primarily consists of its direct-to-consumer (D2C) mental health platform. The online counseling and therapy services are provided via its network of over 40,000 licensed clinicians leveraging its platform for Web, mobile app, phone, and text-based interactions. Its Teladoc Health family of brands, including Teladoc and BetterHelp, deliver access to advice and resolution for an array of healthcare needs.
Calendar
2024-05-23
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
D+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
13.01
USD
Average target price
18.2
USD
Spread / Average Target
+39.86%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -39.63% | 2.2B | |
| +40.45% | 2.68B | |
| +22.83% | 527M | |
| +42.77% | 467M | |
| -64.56% | 156M | |
| -31.65% | 85.12M |
- Stock Market
- Equities
- TDOC Stock
- Funds and ETFs Teladoc Health, Inc.
